Cover Image
市場調查報告書

視網膜前薄膜:主要12個國家的市場預測 (2017∼2027年)

Epiomic Epidemiology Series: Epiretinal Membrane Forecast in 12 Major Markets 2017-2027

出版商 Black Swan Analysis 商品編碼 479874
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
Back to Top
視網膜前薄膜:主要12個國家的市場預測 (2017∼2027年) Epiomic Epidemiology Series: Epiretinal Membrane Forecast in 12 Major Markets 2017-2027
出版日期: 2017年03月01日 內容資訊: 英文 56 Pages
簡介

本報告提供全球主要12個國家的視網膜前薄膜 (ERM)的發病情形相關分析,疾病概要和目前的患病人數,各子類型及性別、各年代 (5歲劃分)的詳細情況,各地區、各民族趨勢,風險要素 (老齡化,其他的眼科疾病病歷等),疾病診斷與預後,主要的症狀和併發症,未來趨勢預測 (今後10年份) 的資訊彙整,為您概述為以下內容。

目錄

  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷方法
  • 各地區/各民族的差異
  • 疾病的預後和臨床過程
  • 患者數的測量方法
  • 視網膜前薄膜的最大患病人數
  • 視網膜前薄膜 (ERM) 患者的特徵
    • 視網膜前薄膜的原因
    • ERM患者的共生病症
    • 突發性ERM患者的共生病症
    • 二次性原因造成的ERM患者的共生病症
  • 文中的簡稱一覽
  • Black Swan Analysis的其他出版刊物
  • Black Swan Analysis的線上、病患人數的資料庫
  • 病患人數的服務
  • 線上價格資料/平台
  • 參考文獻
  • 附錄

圖表一覽

分析觀察對象國家

  • 澳洲
  • 巴西
  • 加拿大
  • 中國
  • 法國
  • 德國
  • 印度
  • 義大利
  • 日本
  • 西班牙
  • 英國
  • 美國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: EPMR0010317

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Epiretinal Membrane in 12 Major Markets

An epiretinal membrane (ERM) is a thin sheet of fibrous tissue that develops on the surface of the macula and can cause problems with central vision.

This report provides the current prevalent population for Epiretinal Membrane across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Australia and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Epiretinal Membrane have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

The following are considered risk factors for developing ERMs:

  • Age (65+)
  • Cataract surgery
  • Other eye surgery
  • Posterior uveitis
  • Eye diseases
  • Retinal tear/detachment
  • Vitreomacular adhesion and traction
  • Diabetic retinopathy

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Epiretinal Membrane market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Epiretinal Membrane and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Epiretinal Membrane's prevalent population.
  • Identify sub-populations within Epiretinal Membrane which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Epiretinal Membrane patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Methodology for quantification of patient numbers
  • Top-line Prevalence for Epiretinal Membrane
  • Features of Epiretinal Membrane Patients
    • Cause of Epiretinal Membranes
    • Comorbidities in patients with Epiretinal Membrane
    • Comorbidities in patients with Idiopathic ERM
    • Comorbidities in patients with ERM due to secondary causes
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Figures

  • OCT image of the retina showing formation of an epiretinal membrane
  • The Age-Related Eye Disease Study maculopathy grading grid, affixed to the photograph of a left eye without age-related macular degeneration

List of Tables

  • Prevalence of Epiretinal Membrane, total (000s)
  • Prevalence of Epiretinal Membrane, males (000s)
  • Prevalence of Epiretinal Membrane, females (000s)
  • Eye affected by ERM, total (000s)
  • Type of ERM, total (000s)
  • Cause of Epiretinal Membrane, total (000s)
  • Cause of CMR, total (000s)
  • Cause of PMF, total (000s)
  • Type of Adhesion in Idiopathic ERM, total (000s)
  • Type of Adhesion in Secondary ERM patients, total (000s)
  • ERM patients with Posterior Straphyloma, total (000s)
  • ERM patients with PVD, total (000s)
  • ERM patients with Metamophopsia, total (000s)
  • ERM patients with Diabetes, total (000s)
  • ERM patients with Hypertension, total (000s)
  • ERM patients with Macular Hole, total (000s)
  • ERM patients with PED, total (000s)
  • ERM patients with CME, total (000s)
  • ERM patients with High Myopia, total (000s)
  • Idiopathic ERM patients with VMT, total (000s)
  • Idiopathic ERM patients with Macular Pseudohole, total (000s)
  • Secondary ERM patients with VMT, total (000s)
  • Secondary ERM patients with Diabetes, total (000s)
  • Secondary ERM patients with BRVO, total (000s)
  • Secondary ERM patients with CRVO, total (000s)
  • Secondary ERM patients with Retinal Detachment, total (000s)
  • Secondary ERM patients with AMD, total (000s)
  • Secondary ERM patients with PDR, total (000s
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • USA Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • Canada Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • Canada Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • France Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • France Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • Germany Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • Germany Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • Italy Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • Italy Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • Spain Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • Spain Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • UK Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • UK Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • Japan Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • Japan Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • India Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • India Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • Australia Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • Australia Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
  • China Prevalence of Epiretinal Membrane by 5-yr age cohort, males (000s)
  • China Prevalence of Epiretinal Membrane by 5-yr age cohort, females (000s)
Back to Top